Artistic style with GnRH agonists alone is limited to 6 months.

Care for longer periods or re-treatment after recurrence ofendometriosis is not recommended, because of these agents’ potentially irreversible adverse effects on bone mineral spacing. Like danazol, GnRH agonists are contraindicated in pregnancy (Pregnancy Construct X) ; therefore, fertile women must be examined before aid to rule out pregnancy.
Also,women should be instructed to use a nonhormonal playing of contraception during direction in the upshot that ovulation shouldoccur.
Aid with GnRH agonists brings nearly complete symptomatic backup of endometriosis, usually within 4 weeks.
In manycases, complete infantile fixation of visible implants can be confirmed by laparoscopy mass communicating. Like danazol, GnRH agonists are more effective against superficial disease than against endometriomas and haveno issue on preexisting adhesions and scar tissue paper.
Although these agents are effective in relieving pelvic pain associated withendometriosis, they have not been shown to be effective in enhancing physiological condition.
In a prospective randomized clinical tribulation,aid with GnRH agonists was found to wait creativeness, with no change in the physical condition rate.
The most common adverse effects associated with GnRH agonists are related to ovarian hormone restraint, including hotflashes, vaginal sobriety, penetration bleeding, decreased libido, mild white meat bump or philia, mild slump, andheadaches (see Fare 6).[73,92-94] Coverall, the adverse signification chart is more favorable thanthat of danazol.
In most studies, fewer patients who are treated with GnRH agonists discontinue management because of adverseeffects than do those treated with danazol.
GnRH Agonists and Add-Back Therapy. Because GnRH agonists induce an estrogen-deficient country, their useis associated with loss of bone mineral concentration.
Although this gist is reversible pursual shorter courses of therapy, long-term use may lead to sustained loss of bone. To prevent bone loss associated with GnRHtherapy, many clinicians prescribe these agents with “add-back therapy” — that is, the acquisition of low-doseestrogen/progestin hormone permutation therapy (HRT).
This is a part of article Artistic style with GnRH agonists alone is limited to 6 months. Taken from "Danocrine (Danazol) Researches" Information Blog